Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 4 , Pages 258-265 , December 2007

Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin

Received 31 March 2007 ,Accepted 30 August 2007.

References 

  1. Kumar MNVR. A review of chitin and chitosan applications. React Funct Polym. 2000;46:1–27
  2. Khor E, Lim LY. Implantable applications of chitin and chitosan. Biomaterials. 2003;24:2339–2349
  3. Kim K, Kwon S, Park JH, Chung H, Jeong SY, Kwon IC, et al. Physicochemical characterizations of self-assembled nanoparticles of glycol chitosan–deoxycholic acid conjugates. Biomacromolecules. 2005;6:1154–1158
  4. Lee KY, Kim JH, Kwon IC, Jeong SY. Self-aggregates of deoxycholic acid–modified chitosan as a novel carrier of adriamycin. Colloid Polym Sci. 2000;278:1216–1219
  5. Liu CG, Desai KGH, Chen XG, Park HJ. Linolenic acid–modified chitosan for formation of self-assembled nanoparticles. J Agric Food Chem. 2005;53:437–441
  6. Chen XG, Lee CM, Park HJ. O/W emulsification for the self-aggregation and nanoparticle formation of linoleic acid-modified chitosan in the aqueous system. J Agric Food Chem. 2003;51:3135–3139
  7. Yoshioka H, Nonaka K, Fukuda K, Kazama S. Chitosan-derived polymer-surfactants and their micellar properties. Biosci Biotech Biochem. 1995;59:1901–1904
  8. Menendez JA, Papadimitropoulou A, Vellon L, Colomer R, Lupu R. A genomic explanation connecting “Mediterranean diet”, olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory “PEA3 transcription factor-PEA3 DNA binding site” complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells. Eur J Cancer. 2006;42:2425–2432
  9. Menéndez JA, del Mar Barbacid M, Montero S, Sevilla E, Escrich E, Solanas M, et al. Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells. Eur J Cancer. 2001;37:402–413
  10. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 1994;263:1600–1603
  11. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46:6387–6392
  12. Son YJ, Jang JS, Cho YW, Chung H, Park RW, Kwon IC, et al. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. J Control Release. 2003;91:135–145
  13. Kim JH, Kim YS, Kim SW, Park H, Kim K, Choi K, et al. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J Control Release. 2006;111:228–234
  14. Park JS, Han TH, Lee KY, Han SS, Hwang JJ, Moon DH, et al. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release. J Control Release. 2006;115:37–45
  15. Park JH, Kwon S, Nam JO, Park RW, Chung H, Seo SB, et al. Self-assembled nanoparticles based on glycol chitosan bearing 5β-cholanic acid for RGD peptide delivery. J Control Release. 2004;95:579–588
  16. Park JH, Kwon S, Lee M, Chung H, Kim JH, Kim YS, et al. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. Biomaterials. 2006;27:119–126
  17. Li YY, Chen XG, Yu LM, Wang SX, Sun GZ, Zhou HY. Aggregation of hydrophobically modified chitosan in solution and at the air-water interface. J Appl Polym Sci. 2006;102:1968–1973
  18. Le-Tien C, Lacroix M, Ispas-Szabo P, Mateescu MA. N-acylated chitosan: hydrophobic matrices for controlled drug release. J Control Release. 2003;93:1–13
  19. Jumma M, Furkert FH, Müller BW. A new lipid emulsion formulation with high antimicrobial efficacy using chitosan. Eur J Pharm Biopharm. 2002;53:115–123
  20. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods. 1989;119:203–210
  21. Govender T, Stolnik S, Garnett MC, Illum L, Davis S. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release. 1999;52:171–185
  22. Rao SB, Sharma CP. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res. 1997;34:21–28
  23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63
  24. He P, Davis SS, Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm. 1998;166:75–88
  25. Calvo P, Vila-Jato JL, Alonso MJ. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int J Pharm. 1997;153:41–50
  26. Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Jain RK. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res. 1994;54:3352–3356
  27. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 1995;55:3752–3756
  28. Yokoyama M, Okano T, Sakurai Y, Ekimoto H, Shibazaki C, Kataoka K, et al. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 1991;51:3229–3236
  29. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol. 2000;156:1363–1380

 No conflict of interest was reported by the authors of this article.

PII: S1549-9634(07)00118-9

doi: 10.1016/j.nano.2007.08.002

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 4 , Pages 258-265 , December 2007

Article Tools

* Image Usage & Resolution